𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p38 MAPK-mediated activation of NF-κB by the RhoGEF domain of Bcr

✍ Scribed by Korus, Malgorzata; Mahon, Gwendolyn M; Cheng, Li; Whitehead, Ian P


Book ID
110066847
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
272 KB
Volume
21
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Roxatidine suppresses inflammatory respo
✍ Eu-Jin Cho; Hyo-Jin An; Ji-Sun Shin; Hye-Eun Choi; Jane Ko; Young-Wuk Cho; Hyung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h